Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member


German family-owned drug major Boehringer Ingelheim said today (May 17) that it is updating health care…

Boehringer IngelheimCombivent RespimatManagementPharmaceuticalProductionRespiratory and Pulmonary

Theravance to split into two, halting speculation of a full takeover by GSK


US drug developer Theravance (Nasdaq: THRX) has announced its intention to create two independent publicly…

Anoro ElliptaBiotechnologyBreo ElliptaGlaxoSmithKlineManagementMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoyalty Management CoTheravanceTheravance Biopharma

Two hurdles to jump for SkyePharma, as it changes CEO


On the same day that UK-based SkyePharma (LSE: SKP) announced that Axel Mueller has resigned as chief…

3MEuropeFinancialFlutiformManagementPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Forest and Almirall see early filing of COPD drug aclidinium with US FDA; Appointment at Almirall


Spain’s largest pharma company Almirall (ALM. MC) and US marketing partner Forest Laboratories (NYSE:…

aclidiniumAlmirallEuropeForest LaboratoriesManagementNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

InterMune prepares for European launch of Esbriet after positive CHMP opinion with management appointments


USA-based InterMune (Nasdaq: ITMN) saw its shares leap 144% to $34.89 after the company revealed that…

EsbrietEuropeInterMuneManagementPharmaceuticalRegulationRespiratory and Pulmonary

Back to top